PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease
Go back to PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease| Pharmacity Corporation (AMEX: PHRM) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $72.32 | |||
| Open | $12.38 | 52 Week Low | $1.25 | |||
| Day High | $12.00 | P/E | N/A | |||
| Day Low | $12.00 | EPS | $0.00 | |||
| Volume | 50,000 | |||||
| (AMEX: PHRRF) | Delayed: 0.18 +0.01 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $ | |||
| Open | $0.17 | 52 Week Low | $ | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $ | |||
| Volume | 198,319 | |||||
